12 July 2017 (Wednesday) - ASH Newsletter

The American Society of Hematology’s newsletter also arrived in my inbox this morning:

The July Bonus Mid-Year Edition features conversations with families united by hematology, highlights from recent hematology/oncology meetings, and more.

FEATURES

It Runs in the Blood Members of four hematology dynasties share how they came to their respective career choices and how they navigate being bound by blood.

PERSPECTIVES

Shouts & Mumblings: A Transplant in Every Kitchen In response to CMS’s recent embrace of outpatient stem cell transplantations, Mikkael Sekeres, MD, imagines the future of at-home medical procedures. CROs and Cons Readers passionately responded to the June 2017 Editor’s Corner, calling for an end to the “bureaucratic madness” that contract research organizations have introduced to the clinical trials process. You Make the Call: Readers' Response Readers responded to a question about a patient with c-Myc positive diffuse large B-cell lymphoma.

NEWS

The Society Pages A look at the latest promotions, grants, and awards in the hematology/oncology community. ASH Directions ASH co-hosts congressional briefing on sickle cell disease, Blood Journal’s impact is on the rise, and more. Latest and Greatest The FDA's Oncologic Drugs Advisory Committee shows support for epoetin biosimilar, number of physicians who own their practices is dropping, and more. On Location Highlights from the 2017 ASCO Annual Meeting and the 22nd Congress of EHA, including risk-adapted treatment approach in pediatric AML and all-trans retinoid acid plus danazol in immune thrombocytopenia.

Read the July Bonus Mid-Year Edition

NEWS CONT'D

Written in Blood The latest research from Blood, including: Population-Based Study Finds Persistent Gaps in Understanding and Identification of VTE Risk Isatuximab Plus Lenalidomide and Dexamethasone Active in Relapsed/Refractory Multiple Myeloma Clonal Hematopoiesis Almost “Inevitable” in Older Adults Blood Advances in a Different Vein Research from recent issues of Blood Advances: Are HCT Patients in Brazil at Increased Risk of Zika and Other Mosquito-Transmitted Infections? Literature Scan Research from other top journals, including: Pembrolizumab Safe and Effective in Heavily Pretreated Patients With Classic Hodgkin Lymphoma Adding Eltrombopag to Immunosuppression Improves Hematologic Response in Patients With Severe Aplastic Anemia

TRAINING & EDUCATION

You Make the Call David Straus, MD, discusses treatment options for a patient with c-Myc positive diffuse large B-cell lymphoma.